140 related articles for article (PubMed ID: 28771848)
1. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
[TBL] [Abstract][Full Text] [Related]
3. Hypertension exhibits 5-HT
García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Ruiz-Remolina L; Rodríguez-Barbero A; Martín ML; Morán A
Hypertens Res; 2019 May; 42(5):618-627. PubMed ID: 30696976
[TBL] [Abstract][Full Text] [Related]
4. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):640-7. PubMed ID: 25854421
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
8. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
García-Pedraza JÁ; López C; Fernández-González JF; Martín ML; Morán A; García-Domingo M
J Pharmacol Sci; 2021 Sep; 147(1):48-57. PubMed ID: 34294372
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
[TBL] [Abstract][Full Text] [Related]
10. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT
Fernández-González JF; García-Pedraza JÁ; Ordóñez JL; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674892
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine oral treatment discloses 5-HT
López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
[TBL] [Abstract][Full Text] [Related]
12. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
13. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat.
Morán A; Fernández MM; Velasco C; Martín ML; San Román L
Br J Pharmacol; 1998 Mar; 123(6):1205-13. PubMed ID: 9559906
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
15. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
16. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed.
Pakdeechote P; Rummery NM; Ralevic V; Dunn WR
Eur J Pharmacol; 2007 Jun; 563(1-3):180-6. PubMed ID: 17367778
[TBL] [Abstract][Full Text] [Related]
17. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
[TBL] [Abstract][Full Text] [Related]
19. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
